placeNew Zealand
Contact Us
Minimally Invasive Therapies / Products / Vessel Sealing / LigaSure™ Curved Jaw Open Sealer/Divider

Overview

Essential Energy in Your Hands

In 1999, we revolutionised surgery with the introduction of LigaSure™ vessel-sealing technology — and we didn’t stop there. Our latest innovation, the LigaSure™ curved jaw device*, brings proven LigaSure™ technology to a reposable device that is both easy to use and cost effective. 

Let’s put the most innovative tools in your hands. And let’s put patients first and work together to redefine the standard of care with LigaSure™ technology in open surgery.

Predictable Patient Outcomes 

LigaSure™ technology:

  • provides control, confidence and consistent vessel sealing1
  • is supported by more than 1,000 peer-reviewed clinical studies and has been used in more than 10 million procedures worldwide2
  • has been shown to significantly reduce post-op pain, length of hospital stay and blood loss compared to alternative ligation methods3,4,5,6

Cost-Effective

LigaSure™ technology helps manage costs by significantly reducing procedure time and patients’ hospital stay4,7,8
Features a reusable clamp along with a disposable single-use electrode to minimise waste compared with single-use devices9

Easy-to-Use

The clamp-like design feels familiar in your hand. It is intuitive for surgeons without previous LigaSure™ experience and allows for excellent control.9
Combining the essential elements of surgery: grasping, sealing and cutting, the exchange of instruments is minimized as compared to mechanical ligation.9

Technology

Since the 1999 introduction of LigaSure™ vessel-sealing technology, we’ve continued to innovate upon the technology creating a suite of advanced energy devices for open and laparoscopic surgery.

External clinical studies comparing LigaSure™ technology to mechanical ligation have shown LigaSure™ technology to:10

   

Decrease operative blood loss5,6,7,11,12,13
   

Reduce peri-operative blood loss5,14,15
   

Cut down procedure time7,10,11,16,17
   

Lessen the length of hospital stay11

 

  • 1. Based on a marketing survey during usability lab conducted by Covidien in the US. report: “LigaSure™ LF3225/LF3225C Curved Jaw, Open Sealer/Divider, Marketing Survey Report of US Validation Lab”, USA, May 2014, R0061090.
  • 2. Based on internal data derived from IRC clinical study research completed on January 22, 2014 and sales research completed on July 9, 2013; US140237.
  • 3. Silva-Filho A, Rodrigues A, Monteiro M, et al. Randomized study of bipolar vessel sealing system versus conventional suture ligature for vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2009; 146(2): 200–203.
  • 4. Ding Z, Wable M, Rane A. Use of LigaSure™ bipolar diathermy system in vaginal hysterectomy. J of Obstet Gynaecol. 2005; 25(1): 49-51. 5. 5.
  • 5. Tamussino K, Afschar P, Reuss J, Perschler M, Ralph G, Winter R. Electrosurgical bipolar vessel sealing for radical abdominal hysterectomy. Gynecol Oncol. 2005;96(2): 320-322.
  • 6. Manouras, Filippakis, Dimitrios et al. Sutureless open low anterior resection with total mesorectal excision for rectal cancer with the use of electrothermal bipolar vessel sealing system. Med Sci Monit, 2007; 13(5): CR224-230.
  • 7. Levy B, Emery L. Randomized Trial of Suture Versus Electrosurgical Bipolar Vessel Sealing in Vaginal Hysterectomy. Obstetrics and Gynecology. 2003 Jul;102(1):147-151.
  • 8. Cronje HS, et al. Electrosurgical bipolar vessel sealing during vaginal hysterectomy. Int J Gynaecol Obstet. 2005 Dec;91(3):243.
  • 9. Based on internal test report #R0058454, LF3225 – Marketing claims China validation lab – plan and report. April 2014.
  • 10. Davis J, Global value dossier for LigaSure™ technology pre-clinical data and summary, Coreva Scientific for Medtronic 2017.
  • 11. Targarona, et al. A prospective randomized comparison of conventional electrosurgery, biopolar computer-controlled electrosurgery and ultrasonic dissection. Operative Outcome and Cost analysis. Surgical Innovation. 2005 Dec;12(4):339-344.
  • 12. Ding Z, et al. Use of LigaSure bipolar diathermy system in vaginal hysterectomy. Journal of Obstetrics Gynaecology. 2005 Jan;25(1):49-51.
  • 13. Leonardo C, et al. Laparoscopic nephrectomy using LigaSure system: preliminary experience. Journal of Endourology. 2005 Oct;19(8):976-8. 7.
  • 14. Daskalopoulos G et al. Electrothermal bipolar coagulation for radical prostatectomies and cystectomies: a preliminary case-controlled study. International Urology and Nephrology. 2004;36(2):181-185.
  • 15. Romano F, et al. Laparoscopic Splenectomy: LigaSure versus EndoGIA: A Comparative Study. J Laparoendoscopic & Adv Surg Techniques. 2007. Vol. 17, No. 6.
  • 16. Leonardo C, et al. Laparoscopic nephrectomy using LigaSure system: preliminary experience. Journal of Endourology. 2005 Oct;19(8):976-8.
  • 17. Cronje HS, et al. Electrosurgical bipolar vessel sealing during vaginal hysterectomy. Int J Gynaecol Obstet. 2005 Dec;91(3):243-5.
About Medtronic
Minimally Invasive Therapies
Contact Us
Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2025 Medtronic